Cancer drug prices cut as India faces 1.56 million cases a year

The NPPA has cut prices of several anti-cancer medicines from November 9. ORF data shows India recorded about 1.56 million cancer cases and 9,02,000 deaths in 2025, second only to China among Asian peers. Lung, breast and oral cancers are the deadliest. India's case fatality rate of 57.8% is lower than most neighbours except China.